Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 7E9P | 7E9P | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(state2, local refinement of the RBD and 35B5 Fab) | |
| 7CHH | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs | Spike glycoprotein, BD-368-2 Fab heavy chain, BD-368-2 Fab light chain |
| 7CHH | 7CHH | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs | Spike glycoprotein, BD-368-2 Fab heavy chain, BD-368-2 Fab light chain |
| 7ENF | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 | |
| 7ENF | 7ENF | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 | |
| 7ENG | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 (local refinement of the RBD and Fab30) | |
| 7ENG | 7ENG | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 (local refinement of the RBD and Fab30) | |
| 7E7B | P02452 | Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate | |
| 7E7B | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate | |
| 7L57 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 | Spike glycoprotein, Fab 2-15 variable domain heavy chain, Fab 2-15 variable domain light chain |
| 7L57 | 7L57 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 | Spike glycoprotein, Fab 2-15 variable domain heavy chain, Fab 2-15 variable domain light chain |
| 6XEY | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 6XEY | 6XEY | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 6XEY | A0A5C2GJG2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 7L56 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43 | |
| 7L56 | 7L56 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43 | |
| 7LSS | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7 | |
| 7LSS | 7LSS | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7 | |
| 7L58 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 | Spike glycoprotein, Fab H4 variable domain heavy chain, Fab H4 variable domain light chain |
| 7L58 | 7L58 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 | Spike glycoprotein, Fab H4 variable domain heavy chain, Fab H4 variable domain light chain |
| 7Y42 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein in complex with all-trans retinoic acid | |
| 7VQ0 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86 | |
| 7VQ0 | 7VQ0 | Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86 | |
| 6ZXN | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1) | Spike glycoprotein, Nanobody Ty1 |
| 6ZXN | 6ZXN | Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1) | Spike glycoprotein, Nanobody Ty1 |
| 7A25 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) | Spike glycoprotein, Sybody 23 |
| 7A25 | 7A25 | Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) | Spike glycoprotein, Sybody 23 |
| 7A29 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation | Spike glycoprotein, Neutralising sybody (Sb23) |
| 7A29 | 7A29 | Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation | Spike glycoprotein, Neutralising sybody (Sb23) |
| 7E7D | P02452 | Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate | |
| 7E7D | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate | |
| 8FGX | 8FGX | Cryo-EM structure of the STAR-0215 Fab in complex with active human plasma kallikrein | |
| 8FGX | P03952 | Cryo-EM structure of the STAR-0215 Fab in complex with active human plasma kallikrein | |
| 8J6F | P08887 | Cryo-EM structure of the Tocilizumab Fab/IL-6R complex | |
| 8J6F | 8J6F | Cryo-EM structure of the Tocilizumab Fab/IL-6R complex | |
| 7MFG | Q6WG00 | Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer | |
| 7MFG | Q289M7 | Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer | |
| 7MFG | 7MFG | Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer | |
| 6WXL | A0A067Y6L0 | Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in complex with an H7 SH13 HA trimer | |
| 6WXL | 6WXL | Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in complex with an H7 SH13 HA trimer | |
| 7L0L | Q4ZH98 | Cryo-EM structure of the VRC316 clinical trial, vaccine-elicited, human antibody 316-310-1B11 in complex with an H2 CAN05 HA trimer | |
| 7L0L | 7L0L | Cryo-EM structure of the VRC316 clinical trial, vaccine-elicited, human antibody 316-310-1B11 in complex with an H2 CAN05 HA trimer | |
| 8D21 | Q6WG00 | Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer | |
| 8D21 | Q289M7 | Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer | |
| 8D21 | 8D21 | Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer | |
| 8WLZ | U5WI05 | Cryo-EM structure of the WIV1 S-hACE2 complex | |
| 8WLZ | A0A346FJN8 | Cryo-EM structure of the WIV1 S-hACE2 complex | |
| 8WLZ | Q9BYF1 | Cryo-EM structure of the WIV1 S-hACE2 complex | |
| 6MID | A0A024B7W1 | Cryo-EM structure of the ZIKV virion in complex with Fab fragments of the potently neutralizing human monoclonal antibody ZIKV-195 | E protein, M protein, monoclonal antibody ZIKV-195 heavy chain,monoclonal antibody ZIKV-195 light chain |
| 6MID | 6MID | Cryo-EM structure of the ZIKV virion in complex with Fab fragments of the potently neutralizing human monoclonal antibody ZIKV-195 | E protein, M protein, monoclonal antibody ZIKV-195 heavy chain,monoclonal antibody ZIKV-195 light chain |
